Research Project
Grant-in-Aid for Scientific Research (C)
The multi-drug screening showed the high sensitivity of a malignant clone of canine mammary gland tumor (cMGT) cell line, CHMp-5b to mitochondrial respiratory chain inhibitors (MRCIs). While Metformin, one of the MRCIs, exhibited its anti-tumor effect through AMPK pathway on low sensitive clonal cell line, CHMp-13a, it induced G0/G1 cell cycle arrest in AMPK-independent manner on CHMp-5b. Cellular nicotinamide adenine dinucleotide (NAD) amount was decreased by metformin which exerted anti-proliferative effect, though the ATP amount was not changed. These results highlighted potential of metformin as a novel treatment for cMGT as well as a novel NAD-dependent mechanism.
All 2015 2014 Other
All Journal Article (2 results) (of which Peer Reviewed: 2 results, Acknowledgement Compliant: 2 results) Presentation (6 results)
The Veterinary Journal
Volume: 205 Issue: 2 Pages: 297-304
10.1016/j.tvjl.2015.04.026
Volume: 205 Issue: 2 Pages: 288-296
10.1016/j.tvjl.2015.04.025